Related Experiment Video

Updated: May 22, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

Specificities of sclerosing cholangitis in childhood

Muriel Girard1, Stéphanie Franchi-Abella, Florence Lacaille

  • 1Pôle médicochirurgical, Hépatologie Pédiatrique, Hôpital Universitaire Necker-Enfants-Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France.

Clinics and Research in Hepatology and Gastroenterology
|May 29, 2012
PubMed

Insights

Sclerosing cholangitis (SC) in children presents diverse forms, with ursodeoxycholic acid as a common treatment. Early interventions like bone marrow or liver transplantation are crucial for severe cases and advanced disease.

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Autoimmune Diseases
  • Transplantation Medicine

Background:

  • Sclerosing cholangitis (SC) is a chronic cholestatic liver disease causing bile duct inflammation and fibrosis.
  • It progresses to biliary cirrhosis and liver failure.
  • Four distinct clinical forms are recognized in children: neonatal, autoimmune, primary, and secondary SC.

Purpose of the Study:

  • To review the clinical characteristics, treatment options, and outcomes of pediatric sclerosing cholangitis.
  • To highlight the role of specific interventions for different forms of SC.
  • To discuss the efficacy and limitations of current therapeutic strategies.

Main Methods:

  • Literature review of pediatric sclerosing cholangitis.
  • Analysis of clinical presentations and etiological factors.
  • Evaluation of treatment modalities including medical therapy and transplantation.

Main Results:

  • Ursodeoxycholic acid is the standard treatment for all SC forms, though its efficacy in preventing cirrhosis progression is unproven.
  • Autoimmune SC shows good response to immunosuppression.
  • Early bone marrow transplantation is essential for preventing SC in immunodeficient patients.
  • Liver transplantation is the definitive treatment for biliary cirrhosis, with low reported recurrence rates in children.

Conclusions:

  • Pediatric SC encompasses varied etiologies and clinical behaviors.
  • Management requires tailored approaches based on SC subtype.
  • While ursodeoxycholic acid is widely used, transplantation remains critical for end-stage liver disease and specific conditions like severe immunodeficiency.

More Related Videos

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates06:10

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Published on: August 23, 2022

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...